Biblio

Export 3292 results:
Author Title Type [ Year(Asc)]
2025
I. De Anda-Duran, Hwang, P. H., Drabick, D. Ag, Andersen, S. L., Au, R., and Libon, D. J., “Neuropsychological phenotypic characteristics in a cohort of community-based older adults: Data from the Framingham Heart Study.”, J Alzheimers Dis, p. 13872877251334608, 2025.
J. A. Luchsinger, Teresi, J. A., Valdez, L., Rosario, D., de Miguel, M., Taylor, D., Singer, J., Chang, N., Fuller, W. S., Boquín, C., Silver, S., Eimicke, J. P., Kong, J., Goldberg, T. E., and Devanand, D. P., “Performance of a smell identification test versus the Mini-Mental Status Exam for the detection of dementia and cognitive impairment among persons with cognitive concerns in primary care.”, J Alzheimers Dis, p. 13872877251345083, 2025.
D. A. Levine, Sussman, J. B., Hayward, R. A., Gałecki, A. T., Whitney, R. T., Briceño, E. M., Gross, A. L., Giordani, B. J., Elkind, M. Sv, Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., and Burke, J. F., “The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals.”, J Alzheimers Dis, p. 13872877241302506, 2025.
Y. Zhai, Lu, K., Yuan, Y., Zhang, Z., Xue, L., Zhao, F., Xu, X., and Wang, H., “Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-κB pathway.”, J Alzheimers Dis, p. 13872877251329439, 2025.
C. Hyun Park, Lee, H., Lee, Y. - M., Lee, B. - D., Moon, E., Suh, H., Kim, K., Kim, H. - J., Shim, H., Pak, K., Choi, K. - U., and Kim, C. - S., “Sex-specific effects of apolipoprotein E ε4 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period.”, J Alzheimers Dis, p. 13872877241313066, 2025.
Z. He, Nie, Y., Zhang, W., Liu, Y., Liu, Y., Xue, H., Ai, S., Feng, H., Zhou, Y., Zhang, J., Liang, Y. Yannis, and Ning, Y., “Social isolation, loneliness, genetic risk, and incident dementia in people with type 2 diabetes mellitus: A population-based cohort study.”, J Alzheimers Dis, p. 13872877251344253, 2025.
H. Kasahara, Ikeda, M., Makioka, K., Nakamura, T., Takahashi, R., Kawarabayashi, T., Sanada, E., Suto, T., Higuchi, T., Tsushima, Y., and Ikeda, Y., “White matter lesions rather than amyloid-β burden are associated with cognitive decline in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251316516, 2025.
2024
O. Rolandsson, Tornevi, A., Steneberg, P., Edlund, H., Olsson, T., Andreasson, U., Zetterberg, H., and Blennow, K., “Acute Hyperglycemia Induced by Hyperglycemic Clamp Affects Plasma Amyloid-β in Type 2 Diabetes.”, J Alzheimers Dis, vol. 99, no. 3, pp. 1033-1046, 2024.
B. Polis and Samson, A. O., “Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1199-1218, 2024.
F. Rajabli, Seixas, A. A., Akgun, B., Adams, L. D., Inciute, J., Hamilton, K. L., Whithead, P. G., Konidari, I., Gu, T., Arvizu, J., Golightly, C. G., Starks, T. D., Laux, R., Byrd, G. S., Haines, J. L., Beecham, G. W., Griswold, A. J., Vance, J. M., Cuccaro, M. L., and Pericak-Vance, M. A., “African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181.”, J Alzheimers Dis, vol. 98, no. 1, pp. 221-229, 2024.
S. M. de la Monte and Tong, M., “Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1703-1726, 2024.
R. Ali Syed, Hayat, M., Qaiser, H., Uzair, M., Al-Regaiey, K., Khallaf, R., Kaleem, I., and Bashir, S., “Aging-Related Protein Alterations in the Brain.”, J Alzheimers Dis, vol. 99, no. s1, pp. S5-S22, 2024.
S. J. Czuczwar, Kocki, J., Miziak, B., Bogucki, J., Bogucka-Kocka, A., and Pluta, R., “Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.”, J Alzheimers Dis, vol. 98, no. 1, pp. 151-161, 2024.
C. Wu, Ruan, T., Yuan, Y., Xu, C., Du, L., Wang, F., and Xu, S., “Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.”, J Alzheimers Dis, vol. 99, no. 3, pp. 1005-1022, 2024.
T. Wang, Yan, S., Shan, Y., Xing, Y., Bi, S., Chen, Z., Xi, H., Xue, H., Qi, Z., Tang, Y., and Lu, J., “Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 901-912, 2024.
A. Noori, Jayakumar, R., Moturi, V., Li, Z., Liu, R., Serrano-Pozo, A., Hyman, B. T., and Das, S., “Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research.”, J Alzheimers Dis, vol. 99, no. s2, pp. S397-S407, 2024.
C. Trieu, Van Harten, A. C., Leeuwis, A. E., Exalto, L. G., Hooghiemstra, A. M., Verberk, I. M. W., Allaart, C. P., La Rocca, H. - P. Brunner-, L Kappelle, J., van Oostenbrugge, R. J., Biessels, G. - J., Teunissen, C. E., and van der Flier, W. M., “Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis.”, J Alzheimers Dis, vol. 98, no. 3, pp. 987-1000, 2024.
A. Aljassabi, Zieneldien, T., Kim, J., Regmi, D., and Cao, C., “Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.”, J Alzheimers Dis, vol. 98, no. 3, pp. 755-772, 2024.
H. M. Lalive, Griffa, A., Carlier, S., Nasuti, M., Di Noto, T., Maréchal, B., Rouaud, O., and Allali, G., “Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 333-343, 2024.
K. Noorda, Noorda, K., Sabbagh, M. N., Bertelson, J., Singer, J., and Decourt, B., “Amyloid-Directed Antibodies: Past, Present, and Future.”, J Alzheimers Dis, vol. 101, no. s1, pp. S3-S22, 2024.
I. Ferrer, “Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging.”, J Alzheimers Dis, vol. 100, no. s1, pp. S153-S164, 2024.
R. W. B. Love, “Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1235-1241, 2024.
R. Pluta, Bogucka-Kocka, A., Bogucki, J., Kocki, J., and Czuczwar, S. J., “Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1375-1383, 2024.
D. A. Loeffler, “Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.”, J Alzheimers Dis, vol. 100, no. 2, pp. 379-411, 2024.
T. Nagata, Nakajima, S., Kito, S., and Shinagawa, S., “The Association Between Distinct Delusional Ideations and Depressive Symptoms in Alzheimer's Disease: A Re-Analysis of CATIE-AD.”, J Alzheimers Dis, vol. 101, no. 2, pp. 661-670, 2024.

Pages